On March 9, Tobira Therapeutics, Inc., announced that it has completed a $13 million convertible note financing. Tobira and Regado Biosciences (NASDAQ: RGDO) entered into a merger agreement that is expected to close in the second quarter of 2015. On Monday shares of Regado Biosciences, Inc. (NASDAQ:RGDO) closed at $1.48.
Walter Energy, Inc. (NYSE:WLT) has been feeling the financial pinch following a year marred with losses, and the downward trend continues after an announcement from the company that it will lay off 46 coal miners at its Brookwood location. This will leave the total number of employees at 1,016, according to a report from AL.com. A spokesperson for the company said the employees laid off will be eligible to reapply for the positions when they come open again. Walter Energy, Inc. (NYSE:WLT) in last trading activity increased 19.95% to close at $0.40. Company weekly performance is -52.74% while its quarterly performance stands at -80.01%. Walter Energy, Inc. (NYSE:WLT) is -95.79% away from its 52 week high.
Johnson & Johnson (NYSE:JNJ) sued rival drugmaker GlaxoSmithKline PLC on Thursday, alleging that Glaxo is trying to unlawfully grab market share with false advertising at the start of spring allergy season in the United States. On last trading day Johnson & Johnson (NYSE:JNJ) increased 1.86% to close at $101.06. Its volatility for the week is 1.35% while volatility for the month is 1.31%. JNJ’s sales growth for past 5 years was 3.70% and its EPS growth for past 5 years was 5.30%. Johnson & Johnson (NYSE:JNJ) monthly performance is 3.38%.
Actavis plc (NYSE:ACT) and Allergan, Inc. announced that the companies received clearance from the European Commission for Actavis’ pending acquisition of Allergan. Clearance by the European Commission satisfies the final regulatory condition to the closing of the pending acquisition, which remains subject to certain customary closing conditions and is expected to be effective on or around March 17, 2015. On Monday shares of Actavis plc (NYSE:ACT) closed at $305.00. Company’s sales growth for last 5 years was 36.10% and EPS growth for next 5 years is recorded as 20.00%.
Northern Oil & Gas (NYSE:NOG) has earned a consensus recommendation of “Hold” from the nine ratings firms that are presently covering the company, Stock Ratings News reports. Seven equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. On last trading day Northern Oil and Gas, Inc. (NYSEMKT:NOG) fell -3.24% to close at $6.86. Its volatility for the week is 6.15% while volatility for the month is 6.93%. NOG’s sales growth for past 5 years was 111.10% and its EPS growth for past 5 years was 102.00%. Northern Oil and Gas, Inc. (NYSEMKT:NOG) monthly performance is -18.14%.